Jim Simons Century Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,022,500 shares of IPSC stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,022,500
Previous 1,185,318
70.63%
Holding current value
$1.05 Million
Previous $568,000
99.3%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IPSC
# of Institutions
63Shares Held
23.3MCall Options Held
33.4KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$2.81 Million0.91% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$1.1 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$886,2000.28% of portfolio
-
Casdin Capital, LLC New York, NY1.23MShares$638,6580.1% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $30.6M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...